[Results of international multicentre non-interventional clinical study of the effectiveness and safety of ascoril expectorant for the treatment of cough in Kazakhstan and Uzbekistan].

T. S. Nurgozhin, A. E. Guliaev, B. A. Ermekbaeva, S. K. Zhaugasheva, G. T. Abuova, É A. An

Research output: Contribution to journalArticle

Abstract

This paper reports results of international multicentre non-interventional clinical study of the effectiveness and safety of ascoril expectorant for the treatment of cough in Kazakhstan and Uzbekistan. The study included 16312 patients examined in different cities during 2011-2012. It showed that ascoril expectorant (Glenmark) at a standard dose is an effective agent for the treatment of cough in children above 3 years and adults aged up to 78 years with ARVI and acute bronchitis, exacerbation of these conditions or grade I-II chronic obstructire pulmonary disease. Most patients reported good therapeutic effect within 1 day after intake. Ascoril expectorant caused no adverse reactions and was well tolerated by the patients. 91% of the attending physicians describe the drug as highly effective.

Original languageEnglish
Pages (from-to)50-55
Number of pages6
JournalKlinicheskaya Meditsina
Volume91
Issue number6
Publication statusPublished - 2013
Externally publishedYes

Fingerprint

Uzbekistan
Kazakhstan
Expectorants
Cough
Safety
Bronchitis
Therapeutic Uses
Lung Diseases
Therapeutics
Physicians
Pharmaceutical Preparations
Clinical Studies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

[Results of international multicentre non-interventional clinical study of the effectiveness and safety of ascoril expectorant for the treatment of cough in Kazakhstan and Uzbekistan]. / Nurgozhin, T. S.; Guliaev, A. E.; Ermekbaeva, B. A.; Zhaugasheva, S. K.; Abuova, G. T.; An, É A.

In: Klinicheskaya Meditsina, Vol. 91, No. 6, 2013, p. 50-55.

Research output: Contribution to journalArticle

Nurgozhin, T. S. ; Guliaev, A. E. ; Ermekbaeva, B. A. ; Zhaugasheva, S. K. ; Abuova, G. T. ; An, É A. / [Results of international multicentre non-interventional clinical study of the effectiveness and safety of ascoril expectorant for the treatment of cough in Kazakhstan and Uzbekistan]. In: Klinicheskaya Meditsina. 2013 ; Vol. 91, No. 6. pp. 50-55.
@article{b997c87db5f54a81a4484a6c5ffbb3b4,
title = "[Results of international multicentre non-interventional clinical study of the effectiveness and safety of ascoril expectorant for the treatment of cough in Kazakhstan and Uzbekistan].",
abstract = "This paper reports results of international multicentre non-interventional clinical study of the effectiveness and safety of ascoril expectorant for the treatment of cough in Kazakhstan and Uzbekistan. The study included 16312 patients examined in different cities during 2011-2012. It showed that ascoril expectorant (Glenmark) at a standard dose is an effective agent for the treatment of cough in children above 3 years and adults aged up to 78 years with ARVI and acute bronchitis, exacerbation of these conditions or grade I-II chronic obstructire pulmonary disease. Most patients reported good therapeutic effect within 1 day after intake. Ascoril expectorant caused no adverse reactions and was well tolerated by the patients. 91{\%} of the attending physicians describe the drug as highly effective.",
author = "Nurgozhin, {T. S.} and Guliaev, {A. E.} and Ermekbaeva, {B. A.} and Zhaugasheva, {S. K.} and Abuova, {G. T.} and An, {{\'E} A.}",
year = "2013",
language = "English",
volume = "91",
pages = "50--55",
journal = "Klinicheskaya Meditsina",
issn = "0023-2149",
publisher = "Izdatel'stvo Meditsina",
number = "6",

}

TY - JOUR

T1 - [Results of international multicentre non-interventional clinical study of the effectiveness and safety of ascoril expectorant for the treatment of cough in Kazakhstan and Uzbekistan].

AU - Nurgozhin, T. S.

AU - Guliaev, A. E.

AU - Ermekbaeva, B. A.

AU - Zhaugasheva, S. K.

AU - Abuova, G. T.

AU - An, É A.

PY - 2013

Y1 - 2013

N2 - This paper reports results of international multicentre non-interventional clinical study of the effectiveness and safety of ascoril expectorant for the treatment of cough in Kazakhstan and Uzbekistan. The study included 16312 patients examined in different cities during 2011-2012. It showed that ascoril expectorant (Glenmark) at a standard dose is an effective agent for the treatment of cough in children above 3 years and adults aged up to 78 years with ARVI and acute bronchitis, exacerbation of these conditions or grade I-II chronic obstructire pulmonary disease. Most patients reported good therapeutic effect within 1 day after intake. Ascoril expectorant caused no adverse reactions and was well tolerated by the patients. 91% of the attending physicians describe the drug as highly effective.

AB - This paper reports results of international multicentre non-interventional clinical study of the effectiveness and safety of ascoril expectorant for the treatment of cough in Kazakhstan and Uzbekistan. The study included 16312 patients examined in different cities during 2011-2012. It showed that ascoril expectorant (Glenmark) at a standard dose is an effective agent for the treatment of cough in children above 3 years and adults aged up to 78 years with ARVI and acute bronchitis, exacerbation of these conditions or grade I-II chronic obstructire pulmonary disease. Most patients reported good therapeutic effect within 1 day after intake. Ascoril expectorant caused no adverse reactions and was well tolerated by the patients. 91% of the attending physicians describe the drug as highly effective.

UR - http://www.scopus.com/inward/record.url?scp=84894475949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894475949&partnerID=8YFLogxK

M3 - Article

C2 - 24417069

AN - SCOPUS:84894475949

VL - 91

SP - 50

EP - 55

JO - Klinicheskaya Meditsina

JF - Klinicheskaya Meditsina

SN - 0023-2149

IS - 6

ER -